Cover Image
Market Research Report

Malaysia Pharmaceuticals & Healthcare Q3 2019

Published by Fitch Solutions, Inc. Product code 179529
Published Content info 71 Pages
Delivery time: 1-2 business days
Back to Top
Malaysia Pharmaceuticals & Healthcare Q3 2019
Published: June 4, 2019 Content info: 71 Pages

Key View:

Innovative pharmaceutical firms will be faced with myriad challenges in Malaysia, ranging from weak intellectual property enforcement to preferential treatment of local manufacturers. Additionally, while the government has adopted a policy which prioritises the welfare of Malaysians, the use of a non-transparent process to issue compulsory licences will continue to undermine investment by innovative drugmakers in the country. As such, Malaysia will remain a highly unattractive market for patented drug launches. Nonetheless, the government's growing investment in healthcare and a rising chronic disease burden will support the growth of the Malaysian pharmaceutical market over the long term.

Table of Contents
Product Code: SSMY03_20190701

Table of Contents

  • Key View
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast
  • Industry Risk/Reward Index
  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Innovative Pharmaceuticals Risk/Reward Index
  • Regulatory Development
  • Regulatory Review
  • Market Overview

Competitive Landscape

  • Company Profile
  • Chemical Company Of Malaysia
  • Kotra Pharma
  • Novartis
  • Ranbaxy Malaysia
  • Sanofi
  • Malaysia Demographic Outlook
  • Pharmaceuticals & Healthcare Glossary
  • Pharmaceuticals & Healthcare Methodology
Back to Top